Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 845, 403065
Abstract
No abstract availableKeywords
Funding Information
- Agentura Pro Zdravotnický Výzkum České Republiky (AZV 15-27580A)
- Grantová Agentura České Republiky (19-10543S)
- Grantová Agentura České Republiky (GACR 18-09709S)
- Grantová Agentura, Univerzita Karlova (GAUK 800216)
- European Regional Development Fund
- Ministerstvo Školství, Mládeže a Tělovýchovy
This publication has 43 references indexed in Scilit:
- Mushroom Ganoderma lucidum Prevents Colitis-Associated Carcinogenesis in MicePLOS ONE, 2012
- Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasionOncogene, 2012
- Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPABiochemical and Biophysical Research Communications, 2011
- Ganoderma lucidum (Reishi) Inhibits Cancer Cell Growth and Expression of Key Molecules in Inflammatory Breast CancerNutrition and Cancer, 2011
- Clonogenic Assay: Adherent CellsJournal of Visualized Experiments, 2011
- 5‐Fluorouracil‐based chemotherapy for colorectal cancer and MTHFR/MTRR genotypesBritish Journal of Clinical Pharmacology, 2010
- Review: Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospectsTherapeutic Advances in Medical Oncology, 2010
- Participation of DNA repair in the response to 5-fluorouracilCellular and Molecular Life Sciences, 2008
- Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenesCancer Science, 2008
- Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF‐7 human breast cancer cellInternational Journal of Cancer, 2002